Investors

Investor Overview

Webcast ImageWebcast - Live
Synta Pharmaceuticals Corp. at Jefferies 2015 Global Healthcare Conference
06/03/15 at 11:30 a.m. ET
Synta Pharmaceuticals Corp. at Jefferies 2015 Global Healthcare Conference
Wednesday, June 3, 2015 11:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Synta Overview
Synta Pharmaceuticals is an innovative, agile biopharmaceutical company focused on research, development and commercialization of novel oncology medicines that have the potential to change the lives of cancer patients. ... More >>
Recent NewsMore >>
DateTitle 
05/28/15Synta Announces Presentations at the 2015 ASCO Annual Meeting
Feasibility of Ganetespib Combination Therapy Demonstrated in Three Investigator-Sponsored Trials STA-12-8666 Results in Pediatric Sarcoma Models Highlighted in Poster Discussion Session LEXINGTON, Mass.--(BUSINESS WIRE)--May 28, 2015-- Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that Phase 1 clinical results from three investigator-sponsored trials evaluating ganetespib combination therapy in ALK-positive lung cancer, ... 
Printer Friendly Version
05/27/15Synta to Present at the Jefferies 2015 Global Healthcare Conference
LEXINGTON, Mass.--(BUSINESS WIRE)--May 27, 2015-- Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company will present at the Jefferies 2015 Global Healthcare Conference on Wednesday, June 3, at 11:30 a.m. (ET) in New York. A live webcast and replay of the presentation will be available on the "Investors" section of the Company's website, www.syntapharma.com. About Synta Pharmaceuticals Synta Phar... 
Printer Friendly Version
05/07/15Synta Reports First Quarter 2015 Financial Results
- Webcast and Conference Call Today, May 7, at 10:00 AM ET - LEXINGTON, Mass.--(BUSINESS WIRE)--May 7, 2015-- Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today reported financial results for the first quarter ended March 31, 2015 and provided an operational update. “We remain encouraged by the progress of our ganetespib clinical program including enrollment in our pivotal, Phase 3 GALAXY-2 trial in non-small cell lung adenocarcinoma, an... 
Printer Friendly Version
04/30/15Synta to Host Conference Call and Webcast of First Quarter 2015 Financial Results on May 7, 2015
LEXINGTON, Mass.--(BUSINESS WIRE)--Apr. 30, 2015-- Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that it will report its first quarter 2015 financial results on Thursday, May 7, 2015, before market open. Following the announcement, management will host a conference call and webcast at 10:00 a.m. ET that morning to discuss the first quarter results and provide operational updates. The conference call can be accessed by ... 
Printer Friendly Version

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
Stock Quote
SNTA (Common)
ExchangeNASDAQ (US Dollar)
Price$2.17
Change (%) Stock is Down 0.02 (0.91%)
Volume1,469,976
Data as of 05/28/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Synta 2014 Form 10-K